Newamsterdam Pharma CO N.V. (NAMSW) — DEF 14A Filings
All DEF 14A filings from Newamsterdam Pharma CO N.V.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
NewAmsterdam Pharma Executive Compensation Details Released
— May 8, 2025 Risk: low
NewAmsterdam Pharma Co N.V. filed a DEF 14A on May 8, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes i -
NewAmsterdam Pharma Announces 2024 Annual General Meeting of Shareholders
— May 9, 2024 Risk: low
NewAmsterdam Pharma Co N.V. (NAMSW) filed a Proxy Statement (DEF 14A) with the SEC on May 9, 2024. The 2024 Annual General Meeting of Shareholders for NewAmster
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX